McKessonMCK
Market Cap: $65.4B
About: McKesson Corp is one of three leading pharmaceutical wholesalers in the us engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the us pharmaceutical wholesale industry. Outside the us market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Employees: 51,000
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
61% more first-time investments, than exits
New positions opened: 151 | Existing positions closed: 94
13% more repeat investments, than reductions
Existing positions increased: 618 | Existing positions reduced: 546
9% more capital invested
Capital invested by funds: $59.8B [Q1] → $65B (+$5.18B) [Q2]
7% more funds holding in top 10
Funds holding in top 10: 41 [Q1] → 44 (+3) [Q2]
4% more funds holding
Funds holding: 1,527 [Q1] → 1,584 (+57) [Q2]
6% more call options, than puts
Call options by funds: $678M | Put options by funds: $639M
0.98% more ownership
Funds ownership: 84.94% [Q1] → 85.92% (+0.98%) [Q2]
Research analyst outlook
10 Wall Street Analysts provided 1 year price targets over the past 3 months
10 analyst ratings
Leerink Partners Michael Cherny 50% 1-year accuracy 12 / 24 met price target | 32%upside $665 | Outperform Maintained | 5 Sept 2024 |
JP Morgan Lisa Gill 67% 1-year accuracy 16 / 24 met price target | 31%upside $661 | Overweight Maintained | 21 Aug 2024 |
Barclays Steve Valiquette 64% 1-year accuracy 7 / 11 met price target | 22%upside $616 | Overweight Maintained | 8 Aug 2024 |
Evercore ISI Group Elizabeth Anderson 56% 1-year accuracy 14 / 25 met price target | 25%upside $630 | Outperform Maintained | 8 Aug 2024 |
Baird Eric Coldwell 53% 1-year accuracy 16 / 30 met price target | 33%upside $671 | Outperform Maintained | 8 Aug 2024 |
Financial journalist opinion
Based on 17 articles about MCK published over the past 30 days